...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Number of shares to compute the price per share

NBB - Sounds like you and I are hoping for the same thing for the same reasons.

tada

 

Share
New Message
Please login to post a reply